Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 26

1.

Size-selective loosening of the blood-brain barrier in claudin-5-deficient mice.

Nitta T, Hata M, Gotoh S, Seo Y, Sasaki H, Hashimoto N, Furuse M, Tsukita S.

J Cell Biol. 2003 May 12;161(3):653-60.

2.

Combinatorial effects of Flk1 and Tal1 on vascular and hematopoietic development in the mouse.

Ema M, Faloon P, Zhang WJ, Hirashima M, Reid T, Stanford WL, Orkin S, Choi K, Rossant J.

Genes Dev. 2003 Feb 1;17(3):380-93.

3.

Making sense of latent TGFbeta activation.

Annes JP, Munger JS, Rifkin DB.

J Cell Sci. 2003 Jan 15;116(Pt 2):217-24. Review.

4.

Targets of transcriptional regulation by two distinct type I receptors for transforming growth factor-beta in human umbilical vein endothelial cells.

Ota T, Fujii M, Sugizaki T, Ishii M, Miyazawa K, Aburatani H, Miyazono K.

J Cell Physiol. 2002 Dec;193(3):299-318.

PMID:
12384983
5.
6.

SB-431542 is a potent and specific inhibitor of transforming growth factor-beta superfamily type I activin receptor-like kinase (ALK) receptors ALK4, ALK5, and ALK7.

Inman GJ, Nicolás FJ, Callahan JF, Harling JD, Gaster LM, Reith AD, Laping NJ, Hill CS.

Mol Pharmacol. 2002 Jul;62(1):65-74.

7.

Endothelial cells genetically selected from differentiating mouse embryonic stem cells incorporate at sites of neovascularization in vivo.

Marchetti S, Gimond C, Iljin K, Bourcier C, Alitalo K, Pouysségur J, Pagès G.

J Cell Sci. 2002 May 15;115(Pt 10):2075-85.

8.

Hematopoietic stem cells differentiate into vascular cells that participate in the pathogenesis of atherosclerosis.

Sata M, Saiura A, Kunisato A, Tojo A, Okada S, Tokuhisa T, Hirai H, Makuuchi M, Hirata Y, Nagai R.

Nat Med. 2002 Apr;8(4):403-9.

PMID:
11927948
9.

Balancing the activation state of the endothelium via two distinct TGF-beta type I receptors.

Goumans MJ, Valdimarsdottir G, Itoh S, Rosendahl A, Sideras P, ten Dijke P.

EMBO J. 2002 Apr 2;21(7):1743-53.

10.

Identification of novel inhibitors of the transforming growth factor beta1 (TGF-beta1) type 1 receptor (ALK5).

Callahan JF, Burgess JL, Fornwald JA, Gaster LM, Harling JD, Harrington FP, Heer J, Kwon C, Lehr R, Mathur A, Olson BA, Weinstock J, Laping NJ.

J Med Chem. 2002 Feb 28;45(5):999-1001.

PMID:
11855979
11.

Multifunctional strands in tight junctions.

Tsukita S, Furuse M, Itoh M.

Nat Rev Mol Cell Biol. 2001 Apr;2(4):285-93. Review.

PMID:
11283726
12.

Flk1-positive cells derived from embryonic stem cells serve as vascular progenitors.

Yamashita J, Itoh H, Hirashima M, Ogawa M, Nishikawa S, Yurugi T, Naito M, Nakao K, Nishikawa S.

Nature. 2000 Nov 2;408(6808):92-6.

PMID:
11081514
13.

Heterozygous germline mutations in BMPR2, encoding a TGF-beta receptor, cause familial primary pulmonary hypertension.

International PPH Consortium, Lane KB, Machado RD, Pauciulo MW, Thomson JR, Phillips JA 3rd, Loyd JE, Nichols WC, Trembath RC.

Nat Genet. 2000 Sep;26(1):81-4.

PMID:
10973254
14.

Functional analysis of the TGFbeta receptor/Smad pathway through gene ablation in mice.

Goumans MJ, Mummery C.

Int J Dev Biol. 2000 Apr;44(3):253-65. Review.

15.

Mechanisms of angiogenesis and arteriogenesis.

Carmeliet P.

Nat Med. 2000 Apr;6(4):389-95. Review.

PMID:
10742145
16.

Activin receptor-like kinase 1 modulates transforming growth factor-beta 1 signaling in the regulation of angiogenesis.

Oh SP, Seki T, Goss KA, Imamura T, Yi Y, Donahoe PK, Li L, Miyazono K, ten Dijke P, Kim S, Li E.

Proc Natl Acad Sci U S A. 2000 Mar 14;97(6):2626-31.

17.

Endothelial claudin: claudin-5/TMVCF constitutes tight junction strands in endothelial cells.

Morita K, Sasaki H, Furuse M, Tsukita S.

J Cell Biol. 1999 Oct 4;147(1):185-94.

18.
19.

Genetic abnormalities in hereditary hemorrhagic telangiectasia.

Marchuk DA.

Curr Opin Hematol. 1998 Sep;5(5):332-8. Review.

PMID:
9776212
20.

TGF-beta signal transduction.

Massagué J.

Annu Rev Biochem. 1998;67:753-91. Review.

PMID:
9759503

Supplemental Content

Support Center